CRWV Form 144: Nitin Agrawal reports multiple 10b5-1 sales
CRWV discloses reported dispositions by Nitin Agrawal via a Form 144 filing.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
CRWV discloses reported dispositions by Nitin Agrawal via a Form 144 filing. The excerpt lists multiple open-market 10b5-1 sales and a grant/transfer of Restricted Stock Units dated 05/20/2026.
The filing shows examples of sales, including 63,157 shares sold on 03/11/2026 for $5,032,349.76 and 38,456 shares sold on 03/17/2026 for $3,200,881.31. The excerpt labels several transactions as 10b5-1 Sales.
Insights
Transactions are routine insider dispositions under 10b5-1 and an RSU transfer.
The excerpt lists multiple open-market 10b5-1 sales by Nitin Agrawal on specific dates and a line for Restricted Stock Units dated 05/20/2026. The filings identify share counts and gross proceeds for each trade.
Cash‑flow treatment and remaining holdings are not shown in the excerpt; subsequent filings may disclose post-transaction positions or withholding details.
Key Figures
Key Terms
10b5-1 regulatory
Restricted Stock Units financial
Form 144 regulatory
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did CRWV's Form 144 report about Nitin Agrawal?
Which sales are highlighted in the excerpt for CRWV (examples)?
Were any transactions identified as 10b5-1 sales in the CRWV filing?
Does the excerpt disclose post-transaction holdings for Agrawal?
AI-generated analysis. How Rhea-AI works. Not financial advice.